Page breadcrumb nav

VAERS Report 2156842

Case Report Section

Vaer Report Details

Age: NA

Gender: Male

State: Outside US

Patient Died?
No
Vaccine information

Name: COVID19 (COVID19 (PFIZER-BIONTECH))

Type: Coronavirus 2019 vaccine

Manufacturer: PFIZER

Lot: fl9994


Date report was received
2022-03-04
Date form completed
Date Vaccinated
2022-02-17
Date of Onset
0
Number of days (onset date – vaccination date)
0
Adverse Event Description

nausea; weakness of arms; headache; arm which received the injection felt very painful when raised it or pressed on the area of needle entry; inappropriate schedule of vaccine administered; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory agency. the reporter is the patient. regulatory number: gb-mhra-webcovid-202202191316130150-9shdb (ra). other case identifier(s): gb-mhra-adr 26625751 (ra). a 43 year-old male patient received bnt162b2 (comirnaty), administration date 17feb2022 (lot number: fl9994) as dose 2, single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. past drug history included: espranor, notes: espranor (buprenorphine) 10mg per day. vaccination history included: comirnaty (dose 1), administration date: 23dec2021, for covid-19 vaccination. the following information was reported: nausea (medically significant) with onset 18feb2022, outcome "recovered" (19feb2022), described as "nausea"; muscular weakness (medically significant) with onset 18feb2022, outcome "not recovered", described as "weakness of arms"; headache (medically significant) with onset 18feb2022, outcome "recovered" (19feb2022), described as "headache"; vaccination site pain (medically significant) with onset 18feb2022, outcome "unknown", described as "arm which received the injection felt very painful when raised it or pressed on the area of needle entry"; inappropriate schedule of product administration (non-serious) with onset 17feb2022, outcome "unknown", described as "inappropriate schedule of vaccine administered". clinical course: patient has not had symptoms associated with covid-19; not had a covid-19 test. patient reported to be fine all day following the injection on the 17feb2021. however, the following day patient woke up with a headache and feeling of nausea. patient would describe it as severe but became fairly mild after a few hours and remained in this condition for the entire day. also, his arm which received the injection felt very painful when raised it or pressed on the area of needle entry, more worryingly it was very weak (had virtually zero grip strength and the limb is too weak to lift a full cup of tea). today (discrepantly reported as 19th january) the headache and nausea feelings have vanished but arm has improved only very slightly and remains very weak. patient has not tested positive for covid-19 since having the vaccine. patient is not enrolled in clinical trial. if this condition doesn't improve before monday, 21feb, patient reported that he will attend gp's practice. no follow-up attempts are possible. no further information is expected

Lab Data
na
List of symptoms
nausea headache muscular weakness inappropriate schedule of product administration vaccination site pain
Patient Died?
No
Date Died
NA
Birth defect
false
Vaccine Administered By:
Other
Vaccine Purchased By:
Unknown
Patient visit ER?
No
Patient Hospitalized?
No
Stay in hospital
No
Days in hospital
Unspecified
Permanent disability?
No
Allergies:
na
Current Illness
na